+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breast Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027

  • ID: 5021872
  • Report
  • March 2020
  • Region: Global
  • 207 pages
  • Transparency Market Research

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • bioTheranostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • MORE
Breast Cancer Diagnostics Market - Scope of the Report

The publisher’s report on the global breast cancer diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global breast cancer diagnostics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global breast cancer diagnostics market for the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global breast cancer diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global breast cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global breast cancer diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global breast cancer diagnostics market. The next section of the global breast cancer diagnostics market report highlights the USPs, which include technological advancements and breast cancer epidemiology.

The report also delves into the competitive landscape of the global breast cancer diagnostics market. Key players operating in the global breast cancer diagnostics treatment market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global breast cancer diagnostics treatment market report.

Key Questions Answered in Global Breast Cancer Diagnostics Market Report
  • What is the sales/revenue generated by different breast cancer diagnostics across all the regions during the forecast period?
  • What are the major drivers, restraints, and opportunities in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2027 and which product will expand at the fastest CAGR during the forecast period?
Breast Cancer Diagnostics Market - Research Objectives and Approach

The comprehensive report on the global breast cancer diagnostics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global breast cancer diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global breast cancer diagnostics market, which includes the publisher analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the breast cancer diagnostics market. The next section of the global breast cancer diagnostics market report highlights the USPs, including technological advancements and breast cancer epidemiology in the global breast cancer diagnostics market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key breast cancer diagnostics manufacturers has been mapped to ascertain the size of the global breast cancer diagnostics market in terms of value. The forecast presented here assesses the total revenue generated by breast cancer diagnostics. In order to provide an accurate forecast, we took into consideration the parent cancer diagnostics market.

The report analyzes the global breast cancer diagnostics market in terms of technique, cancer type, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the breast cancer diagnostics market.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • bioTheranostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Cancer Diagnostics Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Breast Cancer Diagnostics Market Analysis and Forecast, 2018–2028

5. Key Insights
5.1. Technological Advancements
5.2. Breast Cancer Epidemiology, by Key Countries/Region
5.3. Breast Cancer Epidemiology

6. Global Breast Cancer Diagnostics Market Analysis and Forecast, by Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technique, 2018–2028
6.4. Market Attractiveness Analysis, by Technique

7. Global Breast Cancer Diagnostics Market Analysis and Forecast, by Cancer Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Cancer Type, 2018–2028
7.4. Market Attractiveness Analysis, by Cancer Type

8. Global Breast Cancer Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2028
8.4. Market Attractiveness Analysis, by End-user

9. Global Breast Cancer Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.3. Market Attractiveness Analysis, by Country/Region

10. North America Global Breast Cancer Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Technique, 2018–2028
10.4. Market Value Forecast, by Cancer Type, 2018–2028
10.5. Market Value Forecast, by End-user, 2018–2028
10.6. Market Value Forecast, by Country, 2018–2028
10.7. Market Attractiveness Analysis

11. Europe Global Breast Cancer Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Technique, 2018–2028
11.4. Market Value Forecast, by Cancer Type, 2018–2028
11.5. Market Value Forecast, by End-user, 2018–2028
11.6. Market Value Forecast, by Country/Sub-region, 2018–2028
11.7. Market Attractiveness Analysis

12. Asia Pacific Global Breast Cancer Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Technique, 2018–2028
12.4. Market Value Forecast, by Cancer Type, 2018–2028
12.5. Market Value Forecast, by End-user, 2018–2028
12.6. Market Value Forecast, by Country/Sub-region, 2018–2028
12.7. Market Attractiveness Analysis

13. Latin America Global Breast Cancer Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Technique, 2018–2028
13.4. Market Value Forecast, by Cancer Type, 2018–2028
13.5. Market Value Forecast, by End-user, 2018–2028
13.6. Market Value Forecast, by Country/Sub-region, 2018–2028
13.7. Market Attractiveness Analysis

14. Middle East and Africa Global Breast Cancer Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Technique, 2018–2028
14.4. Market Value Forecast, by Cancer Type, 2018–2028
14.5. Market Value Forecast, by End-user, 2018–2028
14.6. Market Value Forecast, by Country/Sub-region, 2018–2028
14.7. Market Attractiveness Analysis

15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • GE Healthcare (General Electric Company)
  • Koninklijke Philips N.V.
  • Hologic, Inc.
  • C. R. Bard, Inc. (Becton, Dickinson and Company)
  • Siemens Healthineers (Siemens AG)
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holding Corporation
  • Leica Biosystems Nussloch GmbH (Danaher)
  • bioTheranostics, Inc.
  • Myriad Genetics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll